Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19547919 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment
Conditions: Extragonadal Germ Cell Tumor;   Ovarian Cancer;   Teratoma;   Testicular Germ Cell Tumor
Intervention: Drug: sunitinib malate

Study has passed its completion date and status has not been verified in more than two years.